Calithera Biosciences Probability of Future Pink Sheet Price Finishing Under 0.041
| CALADelisted Stock | USD 0.05 0.00 0.00% |
Calithera |
Calithera Biosciences Target Price Odds to finish below 0.041
The tendency of Calithera Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 0.04 or more in 90 days |
| 0.05 | 90 days | 0.04 | about 19.45 |
Based on a normal probability distribution, the odds of Calithera Biosciences to drop to $ 0.04 or more in 90 days from now is about 19.45 (This Calithera Biosciences probability density function shows the probability of Calithera Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Calithera Biosciences price to stay between $ 0.04 and its current price of $0.05 at the end of the 90-day period is about 1.7 .
Given the investment horizon of 90 days the pink sheet has the beta coefficient of 19.12 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Calithera Biosciences will likely underperform. In addition to that Calithera Biosciences has an alpha of 10.9052, implying that it can generate a 10.91 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Calithera Biosciences Price Density |
| Price |
Predictive Modules for Calithera Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Calithera Biosciences. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Calithera Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Calithera Biosciences is not an exception. The market had few large corrections towards the Calithera Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Calithera Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Calithera Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 10.91 | |
β | Beta against Dow Jones | 19.12 | |
σ | Overall volatility | 0.15 | |
Ir | Information ratio | 0.11 |
Calithera Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Calithera Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Calithera Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Calithera Biosciences is not yet fully synchronised with the market data | |
| Calithera Biosciences has some characteristics of a very speculative penny stock | |
| Calithera Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (39.65 M) with loss before overhead, payroll, taxes, and interest of (42.7 M). | |
| Calithera Biosciences currently holds about 41.79 M in cash with (43.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.59, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Calithera Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Calithera Pink Sheet often depends not only on the future outlook of the current and potential Calithera Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Calithera Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 5 M | |
| Cash And Short Term Investments | 25.5 M |
Calithera Biosciences Technical Analysis
Calithera Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Calithera Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Calithera Biosciences. In general, you should focus on analyzing Calithera Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Calithera Biosciences Predictive Forecast Models
Calithera Biosciences' time-series forecasting models is one of many Calithera Biosciences' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Calithera Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Calithera Biosciences
Checking the ongoing alerts about Calithera Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Calithera Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Calithera Biosciences is not yet fully synchronised with the market data | |
| Calithera Biosciences has some characteristics of a very speculative penny stock | |
| Calithera Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (39.65 M) with loss before overhead, payroll, taxes, and interest of (42.7 M). | |
| Calithera Biosciences currently holds about 41.79 M in cash with (43.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.59, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in Calithera Pink Sheet
If you are still planning to invest in Calithera Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Calithera Biosciences' history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |